Announcements Trials
Browse Landscape

Phase

Phase 1 12Phase 2 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 31Gastrointestinal 2Thoracic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Colorectal Neoplasms 456Pancreatic Neoplasms 363Stomach Neoplasms 246Carcinoma, Hepatocellular 231Carcinoma, Non-Small-Cell Lung 164Colonic Neoplasms 145Esophageal Neoplasms 133Neoplasms 115Neoplasm Metastasis 114Ovarian Neoplasms 111Rectal Neoplasms 106Liver Neoplasms 101Breast Neoplasms 99Lung Neoplasms 78Melanoma 76Squamous Cell Carcinoma of Head and Neck 70Gastrointestinal Neoplasms 58Endometrial Neoplasms 58Carcinoma, Renal Cell 54Uterine Cervical Neoplasms 52Cholangiocarcinoma 52Biliary Tract Neoplasms 52Triple Negative Breast Neoplasms 49Head and Neck Neoplasms 48Sarcoma 46Prostatic Neoplasms 45Esophageal Squamous Cell Carcinoma 39Urinary Bladder Neoplasms 34Small Cell Lung Carcinoma 31Carcinoma 29

Interventions

pembrolizumab 1binimetinib 1Protein Kinase C 1Crizotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Uveal Melanoma × Gastrointestinal × Clear all
NCT03947385 2026-01-27

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

IDEAYA Biosciences

Phase 1/2 Recruiting
336 enrolled
DermatologicGastrointestinal

Uveal Melanoma, Melanoma, Colorectal Neoplasms

NCT04130516 2025-12-18

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

Linnaeus Therapeutics, Inc.

Phase 1/2 Recruiting
200 enrolled
DermatologicGastrointestinalThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Melanoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡